344 related articles for article (PubMed ID: 24315410)
21. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
Gomes KS; Nunes-De-Souza RL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
[TBL] [Abstract][Full Text] [Related]
22. Role of 5-HT
Vilela-Costa HH; Maraschin JC; Casarotto PC; Sant'Ana AB; de Bortoli VC; Vicente MA; Campos AC; Guimarães FS; Zangrossi H
Behav Brain Res; 2021 Apr; 404():113159. PubMed ID: 33571572
[TBL] [Abstract][Full Text] [Related]
23. 5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus.
de Bortoli VC; Yamashita PS; Zangrossi H
J Psychopharmacol; 2013 Dec; 27(12):1116-23. PubMed ID: 23787365
[TBL] [Abstract][Full Text] [Related]
24. [Involvement of some subtypes of 5-HT2-receptors in affective behavior in female rats].
Fedotova IuO; Ordian NE; Frolova HO; Soboliev VI
Fiziol Zh (1994); 2012; 58(6):75-80. PubMed ID: 23530416
[TBL] [Abstract][Full Text] [Related]
25. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B
Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317
[TBL] [Abstract][Full Text] [Related]
26. Directly Observable Behavioral Effects of Lorcaserin in Rats.
Serafine KM; Rice KC; France CP
J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
[TBL] [Abstract][Full Text] [Related]
27. Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
Vicente MA; Zangrossi H
Neuropharmacology; 2014 Apr; 79():127-35. PubMed ID: 24275045
[TBL] [Abstract][Full Text] [Related]
28. Dorsal-striatal 5-HT₂A and 5-HT₂C receptors control impulsivity and perseverative responding in the 5-choice serial reaction time task.
Agnoli L; Carli M
Psychopharmacology (Berl); 2012 Jan; 219(2):633-45. PubMed ID: 22113450
[TBL] [Abstract][Full Text] [Related]
29. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
30. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT).
Fox MA; Stein AR; French HT; Murphy DL
Br J Pharmacol; 2010 Feb; 159(4):879-87. PubMed ID: 20128812
[TBL] [Abstract][Full Text] [Related]
31. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
de Bortoli VC; Nogueira RL; Zangrossi H
Psychopharmacology (Berl); 2006 Jan; 183(4):422-8. PubMed ID: 16258751
[TBL] [Abstract][Full Text] [Related]
32. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
Freo U; Merico A; Ermani M; Ori C
Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
[TBL] [Abstract][Full Text] [Related]
33. The role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder.
Flaisher-Grinberg S; Klavir O; Joel D
Int J Neuropsychopharmacol; 2008 Sep; 11(6):811-25. PubMed ID: 18339223
[TBL] [Abstract][Full Text] [Related]
34. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Bagdy G; Graf M; Anheuer ZE; Modos EA; Kantor S
Int J Neuropsychopharmacol; 2001 Dec; 4(4):399-408. PubMed ID: 11806866
[TBL] [Abstract][Full Text] [Related]
35. The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Wingen M; Kuypers KP; Ramaekers JG
Psychopharmacology (Berl); 2007 Feb; 190(3):391-400. PubMed ID: 17124621
[TBL] [Abstract][Full Text] [Related]
36. 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen.
Pockros LA; Pentkowski NS; Conway SM; Ullman TE; Zwick KR; Neisewander JL
Synapse; 2012 Dec; 66(12):989-1001. PubMed ID: 22886755
[TBL] [Abstract][Full Text] [Related]
37. Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex.
Nocjar C; Alex KD; Sonneborn A; Abbas AI; Roth BL; Pehek EA
Neuroscience; 2015 Jun; 297():22-37. PubMed ID: 25818050
[TBL] [Abstract][Full Text] [Related]
38. Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.
Egashira N; Okuno R; Shirakawa A; Nagao M; Mishima K; Iwasaki K; Oishi R; Fujiwara M
Biol Pharm Bull; 2012; 35(3):376-9. PubMed ID: 22382324
[TBL] [Abstract][Full Text] [Related]
39. The postnatal 5-HT
Ishikawa C; Shiga T
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():66-74. PubMed ID: 28483674
[TBL] [Abstract][Full Text] [Related]
40. Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission.
Herian M; Wojtas A; Sobocińska MK; Skawski M; González-Marín A; Gołembiowska K
Pharmacol Rep; 2020 Dec; 72(6):1593-1603. PubMed ID: 33174181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
